Congress Symposia
Register today for one of the following CME/CE-accredited breakfast symposia held during the Society of Critical Care Medicine’s (SCCM) 39th Critical Care Congress.
Sponsored symposia are complimentary ticketed sessions designed to promote quality improvements in healthcare and provide a balanced view of available therapeutic options for intensive care units.
All registered Congress attendees are welcome to participate in these popular sessions. Register early. Seating is limited and issued on a first-come, first-served basis.
Sunday, January 10, 2010
6:30 a.m. – 8:00 a.m.
Sponsored Symposium
Addressing the MRSA Crisis: A Paradigm Shift Beyond Vancomycin in the ICU
Supported by an educational grant from Astellas Pharma US, Inc.
Moderator: Thomas File
LEARNING OBJECTIVES
• Identify the characteristics and pathogenesis of methicillin-resistant Staphylococcus aureus (MRSA) infections in the ICU
• Evaluate how to optimize vancomycin therapy for MRSA infections
• Select an appropriate antimicrobial agent to treat MRSA infections using evidence-based strategies
6:30 a.m. – 7:00 a.m.
The MRSA Crisis: Epidemiological Trends in the ICU
Thomas File
7:00 a.m. – 7:30 a.m.
Appropriate Use of Vancomycin for MRSA Infections
Michael Rybak
7:30 a.m. – 8:00 a.m.
Strategies for Selection of Anti-MRSA Agents in the Severely Ill
Donald E. Craven
Sunday, January 10, 2010
6:30 a.m. – 8:00 a.m.
Sponsored Symposium
Delirium Should “Never” Occur: But If It Does . . .
Supported by an educational grant from Hospira
Moderator: John W. Devlin
LEARNING OBJECTIVES
• Review the risk factors for delirium
• Discuss the role of dexmedetomidine in the treatment of delirium
• Discuss the role of atypicals in the treatment of delirium
6:30 a.m. – 7:00 a.m.
Delirium: The Next Proposed “Never Event.” Is This Realistic?
Pratik P. Pandharipande
7:00 a.m. – 7:30 a.m.
Haloperidol: The “Go-To” Drug. Are Atypicals a Better Option?
John W. Devlin
7:30 a.m. – 8:00 a.m.
Haloperidol: The “Go-To” Drug. Is Dexmedetomidine a Better Option?
Richard R. Riker
Sunday, January 10, 2010
6:30 a.m. – 8:00 a.m.
Sponsored Symposium
Evidence-Based Nutritional Guidelines in 2010
Supported by an educational grant from Abbott Nutrition, a division of Abbott Laboratories, Inc.
Moderator: Naomi Jones
LEARNING OBJECTIVES
• Describe areas within the guidelines supported by strong evidence as well as those with weak evidence
• Describe the characteristics of hospitals that have been successful at guideline implementation
• Discuss future areas of research to strengthen the evidence-based recommendations
6:30 a.m. – 7:00 a.m.
SCCM/A.S.P.E.N. Nutrition Guidelines: Examination of the Evidence
Stephen McClave
7:00 a.m. – 7:30 a.m.
Implementation of Nutrition Guidelines: Who Succeeds and Why?
Naomi Jones
7:30 a.m. – 8:00 a.m.
The Future of Nutrition Therapy: Looking into the Crystal Ball
Paul Wischmeyer
Sunday, January 10, 2010
6:30 a.m. – 8:00 a.m.
Sponsored Symposium
Severe Blood Pressure Elevations In The Intensive Care Unit
Sponsored by an educational grant from The Medicines Company
Moderator: Jerrold H. Levy
LEARNING OBJECTIVES
• Describe the pathophysiology of acute blood pressure elevations in the ICU setting and the potential adverse events on target organs
• List optimal strategies for controlling elevated blood pressure and intracranial pressure in the neurocritical care setting
• Compare strategies used in real-world case studies for reducing blood pressure in the ICU
6:30 a.m. – 7:00 a.m.
Optimizing Management of Acute Blood Pressure Elevations in the Critical Care Setting
Jerrold H. Levy
7:00 a.m. – 7:30 a.m.
Targeting the Safety and Efficacy Zone for Blood Pressure Control in the Neurocritical Care Environment
Paul M. Vespa
7:30 a.m. – 8:00 a.m.
Complex and Challenging Cases in Acute Pressure Syndromes
Faisal N. Masud
Sunday, January 10, 2010
6:30 a.m. – 8:00 a.m.
Sponsored Symposium
The Science and Medicine of Sepsis Management
Sponsored by an educational grant from Eisai, Inc.
Moderator: Mitchell P. Fink
LEARNING OBJECTIVES
• Describe the prognostic factors that determine clinical outcomes of patients with severe sepsis
• Document the potential pathophysiological and clinical impact of modulating toll-like receptor (TRL) -derived signals in order to mitigate adverse effects of immune responses observed in septic shock syndrome
• Discuss emerging strategies for improving patient care and clinical outcomes for severe sepsis syndrome
• Analyze and evaluate evolving strategies for improving outcomes in sepsis that are focused on suitable targets for interrupting the inflammatory cascade
6:30 a.m. – 7:00 a.m.
The Immuno-Pathophysiology of the Sepsis Disease State
H. Shaw Warren
7:00 a.m. – 7:30 a.m.
Focus on the Role of the TLR-Mediated Signaling System in Sepsis
Ismail Cinel
7:30 a.m. – 8:00 a.m.
Clinical Trials with TLR Antagonists
Mitchell P. Fink
Registration
Space is limited. Register today to secure your seat.
If you haven’t registered for Congress, visit the Congress registration Webpage for registration options. If you have registered for Congress and would like to attend a symposium, download the symposia registration form or call SCCM Customer Service at +1 847 827-6888.
Pre-registration will be accepted until December 10, 2009. Thereafter, registrations will be accepted on site only. Attendees must be registered for SCCM’s 39th Critical Care Congress to attend a sponsored symposium.